Table 4.
Nosocomial infection rate for investigatory referral | Delay (months) |
Age band | |||||
30–39 years | 40–49 years | 50–59 years | 60–69 years | 70–79 years | 80+ years | ||
1% | 2 months | 0.09% | 0.09% | 0.08% | 0.06% | 0.04% | 0.01% |
4 months | 0.21% | 0.22% | 0.21% | 0.20% | 0.20% | 0.19% | |
6 months | 0.35% | 0.38% | 0.36% | 0.36% | 0.37% | 0.36% | |
2.5% | 2 months | 0.08% | 0.09% | 0.06% | 0.01% | −0.08% | −0.22% |
4 months | 0.20% | 0.22% | 0.19% | 0.14% | 0.07% | −0.05% | |
6 months | 0.35% | 0.37% | 0.34% | 0.30% | 0.24% | 0.12% | |
5% | 2 months | 0.08% | 0.08% | 0.03% | −0.09% | −0.29% | −0.60% |
4 months | 0.20% | 0.21% | 0.15% | 0.04% | −0.14% | −0.44% | |
6 months | 0.34% | 0.36% | 0.30% | 0.20% | 0.02% | −0.28% |
This analysis assumes no FIT triage. Green indicates survival benefit from prompt investigatory referral vs delay; red indicates survival disbenefit from prompt investigatory referral vs delay.